<?xml version="1.0" encoding="UTF-8"?>
<p>The first clinical study assessing skullcap's effect on mood was performed on nineteen patients and had positive results [
 <xref rid="B167" ref-type="bibr">167</xref>]. In 2014, Brock et al. published the results of a larger randomized controlled clinical trial designed to assess the effect of a 
 <italic>S. lateriflora</italic> extract on mood in healthy volunteers. Results indicated that global mood was significantly enhanced in individuals who received 350â€‰mg of plant extract for two weeks without negative effects on energy and cognition [
 <xref rid="B164" ref-type="bibr">164</xref>]. Taking into account the fact that anxiety is a well-known enhancer of pain perception [
 <xref rid="B168" ref-type="bibr">168</xref>], 
 <italic>S. lateriflora</italic> extracts could have clinical value as co-analgesics. Additionally, ethanolic and aqueous 
 <italic>S. lateriflora</italic> extracts have been shown to have potent antioxidant effects, reducing ROS and lipid peroxides in tissue homogenates [
 <xref rid="B169" ref-type="bibr">169</xref>], most likely due to the flavonoids it contains.
</p>
